About
Ellipsis Health builds Sage, an emotionally intelligent AI Care Manager that makes and receives autonomous phone calls to automate enrollment, assessments, engagement, and clinical follow-ups. It sells to health plans, health systems, specialty-care organizations, and pharmaceutical companies; its differentiation is patented vocal-biomarker and Empathy Engine technology that detects vocal cues and adapts conversations, supported by clinical research and real-world validation.
Market
Ellipsis Health competes in healthcare conversational AI and automated care-management software, selling 24/7 voice-based engagement to health plans, health systems, specialty-care organizations, and pharma. It positions Sage as an emotionally intelligent, agentic AI care manager for complex physical, behavioral, and social needs, rather than a generic contact-center bot. Its differentiation is the Empathy Engine—patented vocal biomarkers plus therapeutic techniques and training on millions of clinical calls—combined with autonomous assessments, adaptive conversations, and integration into Salesforce Health Cloud and existing care-management workflows.
Ideal customers are enterprise and larger healthcare organizations—health plans, health systems, specialty-care management organizations, and pharma—with complex patient/member populations and high-volume care-management workflows. Primary buyers are likely payer/provider care-management, clinical-operations, and population-health leaders seeking 24/7 outreach, assessments, and follow-ups without adding staff.
At a Glance
Problem
Ellipsis Health addresses the capacity and cost problems that make healthcare care management difficult to scale. Health plans, providers, and care-management organizations face staffing shortages, rising costs, and growing patient needs, particularly among high-risk, high-cost members with complex physical, behavioral, and social needs. The operational pain includes labor-intensive outreach, call-center demand, and the difficulty of delivering consistent support between clinical encounters.
The main use case is longitudinal engagement for complex populations: health-risk assessments, post-discharge follow-up, care-transition coordination, benefits and eligibility questions, and targeted quality-gap outreach. By automating these repetitive but clinically important interactions, Ellipsis aims to extend care-team capacity while containing operating costs and improving member engagement.
Product / Service
The company’s core product is Sage, an AI Care Manager that conducts autonomous, voice-based virtual-care-management calls. Sage is designed to be empathetic, consistent, multilingual, and capable of handling complex cases. Its Empathy Engine uses patented vocal-biomarker technology and training on millions of live clinical calls to provide context-aware support, while its integration with Salesforce Health Cloud connects the agent to clinical workflows.
Ellipsis sells a 24/7 care-management capability to health plans, health systems, specialty-care organizations, and pharmaceutical companies. Sage can support enrollment, benefits and eligibility verification, copay checks, member questions, HEDIS-gap outreach, risk-adjustment work, specialty-care education, and post-discharge programs. The delivery model is enterprise-oriented, with turnkey implementation, API-first integration, FHIR support, and connections to EMR and hospital-management systems; the intended benefits are lower call volume, expanded care-team capacity, more consistent outreach, and improved operational and patient outcomes.
Market
Ellipsis competes in the emerging market for AI-enabled care management, care navigation, and healthcare voice agents. Its buyers are institutional healthcare organizations rather than individual consumers, and its positioning is differentiated by combining conversational voice automation with clinical context and emotional-intelligence capabilities. The competitive set includes adjacent care-navigation platforms such as Hippocratic AI, Kouper Health, Ferry Health, and Solace Health, as well as voice-agent companies identified in market profiles such as Assort Health, Syllable, and Vital.
The company has meaningful commercialization signals rather than appearing to be merely pre-revenue. In June 2025 it announced a $45 million Series A backed by Salesforce, Khosla Ventures, and CVS Health Ventures, with plans to expand Sage across providers, payers, and care-management organizations. Ellipsis also says it is trusted by leading providers and payers, but the sources reviewed do not disclose audited revenue, customer counts, or contract-level traction, so funding and stated enterprise adoption are the clearest public indicators of scale.
Founders & Leadership
Funding History
Khosla Ventures, Bayes Ventures, Marie Hurabiell, Matt Salmonson, Tony Ambegaoker
SJF Ventures
Salesforce, Khosla Ventures, CVS Health Ventures
Recent News
Ellipsis Health announced the appointment of Daniel Bensimhon, MD, as its Chief Clinical Officer.
HealthEdge announced a strategic partnership with Ellipsis Health to integrate Sage into its Care Solutions suite. The integration uses member data from GuidingCare to automate personalized outreach for health risk assessments, post-discharge follow-up, risk profiling, care-gap closure, and enrollment programs.
Epic’s Showroom lists Ellipsis Health’s Sage as integrated with Epic via FHIR. The integration is designed to automate patient outreach and assessments while supporting earlier detection of anxiety, depression, and stress.
Ellipsis Health described Sage’s availability through Salesforce AppExchange and its tight integration with Salesforce Agentforce Health. The company said the low-configuration deployment enables repeatable assessments and follow-up within weeks.
Ellipsis Health launched Sage on Salesforce AppExchange for Agentforce Health users. The integration supports automated patient assessments, risk evaluations, follow-up, documentation, and clinical scoring, with connectivity to clinical data sources and EHRs through APIs.
Active Roles
16Business Model
Ellipsis makes money by selling enterprise deployments of Sage, its AI care-management solution, to health plans, health systems, specialty-care organizations, and pharmaceutical companies. Public materials promote customer deployments and demo-based sales but do not disclose a specific pricing metric or rate card.
Products
Customers
Tech Stack
Similar Companies
Competitors
Key Investors
Salesforce, CVS Health Ventures, Khosla Ventures, E12 Venture Capital, AME Cloud Ventures